Surely by now you have at least once head about a compound known as THC. This name is short for Tetrahydrocannabinol, and this compound is the one that is responsible for the psychological effects of marijuana.
Many times it was proven that the THC is a very powerful compound. It is an active component which has the ability to provide pain relief, therefore it is useful for many conditions. The cannabis is used by man people who are trying to relieve from the symptoms of HIV, stroke recovery, post-traumatic stress disorder (PTSD), and chemotherapy. But the latest researches found that the THC is highly beneficial for the treatment of Alzheimer’s disease.
Also a couple of studies have discovered that the cannabinoids could have neuroprotective properties. A study done back in 2016 by the Salk Institute, may have even found that the THC and some other cannabinoids from the marijuana can promote cellular removal of amyloid beta, which is a toxic protein connected with Alzheimer’s disease.
David Schubert from the Salk Institute says:
Different examinations have offered proof that cannabinoids may be neuroprotective against the manifestations of Alzheimer’s, we trust our investigation is the first to show that cannabinoids influence both irritation and amyloid beta gathering in nerve cells.
The human body was worked with regular cannabinoid receptors, and keeping in mind that the body creates its very own endocannabinoids, exogenous cannabinoids can likewise impact the body’s endocannabinoid system to discharge cancer prevention agents which help to fix cell damage.
THC communicates with both CB1 and CB2 receptors, which are found all through the body. In the brain, cannabinoid receptors are moved in neurons that are related with time perception, pleasure, thinking, coordination and memory. Since THC can likewise cooperate with these correspondence pathways, in the wake of utilizing cannabis you may overlook how to accomplish something, laugh about it, feel happy and afterward go find some snacks.
Research has recommended that THC may give beneficial outcomes to the maturing cerebrum. While we’re not by any stretch of the imagination beyond any doubt how Alzheimer’s is showed, it is identified with a development of two sorts of injuries. One type of sore is known as amyloid plaque (beta amyloid), the sign of Alzheimer’s infection, and the second are neurofibrillary tangles (tau proteins).
While there’s no conclusive answer with respect to why these injuries show up, perpetual irritation doesn’t profit plaques or neurofibrillary tangles, infact inflammation appears to multiply the condition.
One of the colleagues at the Salk Institute said:
Inflammation inside the mind is a noteworthy segment of the harm related with Alzheimer’s disease.
Finding that THC might be engaged with shielding neurons from kicking the bucket notwithstanding supporting the cell evacuation of amyloid beta, is no little accomplishment. This is the reason the organization is hoping to perform tried clinical trials. Since introductory proof in 2016, the Salk Institute was moving towards testing with mice, which could then move to people.
The goal was to begin the testings by 2017, but the testings have yet to come into fruition. But with the policy changes now happening in the U.S. this is going to be a lot easier. The evidence now we have is far to good to ignore, so let us only hope and keep our fingers crossed for the near future.